Stallergenes Greer

Stallergenes Greer is a global biopharmaceutical company specialising in allergy therapeutics through the research, development and commercialisation of allergen immunotherapy products and services. Supported by more than 100 years of expertise and innovation, our products are available for patients in over 40 countries. Our purpose is to enable precision medicine to improve life for people with allergies. With more than 1,100 employees worldwide and manufacturing facilities in both Europe and the United States, Stallergenes Greer is driving a continuing leadership in allergy immunotherapy. Link to our privacy policy: https://www.stallergenesgreer.com/personal-data-protection-policy